GOALS OF WORK: This study sought to characterize the range of oral symptoms and affect upon quality of life reported by pediatric and adolescent patients in relation to the severity of oral mucositis and symptom burden during chemotherapy. PATIENTS AND METHODS: A multicenter study included 140 patients between 6 and 18 years of age who had been treated with chemotherapy. Participants completed the self-report Mouth and Throat Soreness-related Questions of the Oral Mucositis Daily Questionnaire (OMDQ) for 14 days and the Oral Mucositis-specific Quality of Life Measure (OMQoL) at baseline, day 7, and day 14. MAIN RESULTS: The incidences of non-severe and severe mucositis were 23% (n = 32) and 18% (n = 25), respectively. The symptoms reported by the patients with oral mucositis were related to eating (82.4%), swallowing (78.9%), drinking (75.4%), sleeping (71.9%), and talking (43.9%). Approximately 39% (22 out of 57) of patients with mucositis reported at least two simultaneous symptoms resulting from oral mucositis. About a quarter of them (25%, 14 out of 57) reported having all five symptoms concurrently. The mean area under curve (AUC) scores for symptom severity were significantly higher in the severe mucositis group (mean 0.95 to 1.21; 95% CI 0.76 to 1.34) compared with the non-severe (mean 0.50 to 1.06; 95% CI 0.35 to 1.30) and the without mucositis (mean 0 to 0.09; 95% CI 0 to 0.12) groups (p < 0.001). Wald's method generated two clusters: a low-symptom group (n = 102; 72.9%) and a high-symptom group (n = 38; 27.1%). The high-symptom group reported significantly lower mean AUC OMQoL subscale scores (mean 62.2 to 79.2; 95% CI 55.9 to 88.2 versus mean 93.1 to 97.1; 95% CI 91.7 to 98.3, respectively; p < 0.001) and higher mean AUC distress score (mean 1.9 ± 0.5; 95% CI 1.7 to 2 versus mean 1.1 ± 0.2; 95% CI 1.1 to 1.1, respectively; p < 0.001) than the low-symptom group. Swallowing and sleeping had the strongest standardized coefficients in OMQoL subscale scores (swallowing: -0.321 to -0.767; sleeping: -0.406 to -0.773), as well as distress scores (0.468 and 0.557, respectively). CONCLUSIONS: Severe oral mucositis is a common cause of morbidity in pediatric and adolescent patients undergoing chemotherapy. High-symptom burden due to mucositis may have profound impacts on patient quality of life and levels of psychological distress.
GOALS OF WORK: This study sought to characterize the range of oral symptoms and affect upon quality of life reported by pediatric and adolescent patients in relation to the severity of oral mucositis and symptom burden during chemotherapy. PATIENTS AND METHODS: A multicenter study included 140 patients between 6 and 18 years of age who had been treated with chemotherapy. Participants completed the self-report Mouth and Throat Soreness-related Questions of the Oral Mucositis Daily Questionnaire (OMDQ) for 14 days and the Oral Mucositis-specific Quality of Life Measure (OMQoL) at baseline, day 7, and day 14. MAIN RESULTS: The incidences of non-severe and severe mucositis were 23% (n = 32) and 18% (n = 25), respectively. The symptoms reported by the patients with oral mucositis were related to eating (82.4%), swallowing (78.9%), drinking (75.4%), sleeping (71.9%), and talking (43.9%). Approximately 39% (22 out of 57) of patients with mucositis reported at least two simultaneous symptoms resulting from oral mucositis. About a quarter of them (25%, 14 out of 57) reported having all five symptoms concurrently. The mean area under curve (AUC) scores for symptom severity were significantly higher in the severe mucositis group (mean 0.95 to 1.21; 95% CI 0.76 to 1.34) compared with the non-severe (mean 0.50 to 1.06; 95% CI 0.35 to 1.30) and the without mucositis (mean 0 to 0.09; 95% CI 0 to 0.12) groups (p < 0.001). Wald's method generated two clusters: a low-symptom group (n = 102; 72.9%) and a high-symptom group (n = 38; 27.1%). The high-symptom group reported significantly lower mean AUC OMQoL subscale scores (mean 62.2 to 79.2; 95% CI 55.9 to 88.2 versus mean 93.1 to 97.1; 95% CI 91.7 to 98.3, respectively; p < 0.001) and higher mean AUC distress score (mean 1.9 ± 0.5; 95% CI 1.7 to 2 versus mean 1.1 ± 0.2; 95% CI 1.1 to 1.1, respectively; p < 0.001) than the low-symptom group. Swallowing and sleeping had the strongest standardized coefficients in OMQoL subscale scores (swallowing: -0.321 to -0.767; sleeping: -0.406 to -0.773), as well as distress scores (0.468 and 0.557, respectively). CONCLUSIONS: Severe oral mucositis is a common cause of morbidity in pediatric and adolescent patients undergoing chemotherapy. High-symptom burden due to mucositis may have profound impacts on patient quality of life and levels of psychological distress.
Authors: P J Stiff; H Erder; W I Bensinger; C Emmanouilides; T Gentile; J Isitt; Z J Lu; R Spielberger Journal: Bone Marrow Transplant Date: 2006-02 Impact factor: 5.483
Authors: Joel B Epstein; Jennifer L Beaumont; Clement K Gwede; Barbara Murphy; Adam S Garden; Ruby Meredith; Quynh-Thu Le; David Brizel; John Isitt; David Cella Journal: Cancer Date: 2007-05-01 Impact factor: 6.860
Authors: Luciane B Cruz; Anelise S Ribeiro; Angela Rech; Lauro G N Rosa; Cláudio G Castro; Algemir L Brunetto Journal: Pediatr Blood Cancer Date: 2007-04 Impact factor: 3.167
Authors: Jennifer A Kushner; Herenia P Lawrence; Irit Shoval; Thomas L Kiss; Gerald M Devins; Linda Lee; Howard C Tenenbaum Journal: J Can Dent Assoc Date: 2008-02 Impact factor: 1.316
Authors: S L C Figliolia; D T Oliveira; M C Pereira; J R P Lauris; A R Maurício; D T Oliveira; M L Mello de Andrea Journal: Oral Dis Date: 2008-08-22 Impact factor: 3.511
Authors: Camila Weissheimer; Marina Curra; Lauro J Gregianin; Liane E Daudt; Vivian P Wagner; Marco Antonio T Martins; Manoela D Martins Journal: Lasers Med Sci Date: 2017-08-24 Impact factor: 3.161
Authors: Rafaela Maia Almendra Mattos; Regina Maria Holanda de Mendonça; Simone Dos Santos Aguiar Journal: Support Care Cancer Date: 2019-05-23 Impact factor: 3.603
Authors: Karis Kin Fong Cheng; Vincent Lee; Chak Ho Li; Hui Leung Yuen; Wan Yim Ip; Hong Gu He; Joel B Epstein Journal: Support Care Cancer Date: 2013-03-08 Impact factor: 3.603
Authors: Sebastian Hoefert; Martin Grimm; Feraydoon Sharghi; Andreas Geist; Michael Krimmel; Siegmar Reinert Journal: Oral Maxillofac Surg Date: 2014-05-15
Authors: Isabella Lima Arrais Ribeiro; Sâmara Munique Silva; Rebecca Rhuanny Tolentino Limeira; Paulo Rogério Ferreti Bonan; Ana Maria Gondim Valença; Eufrásio Andrade de Lima Neto; Ricardo Dias de Castro Journal: J Appl Oral Sci Date: 2019-11-25 Impact factor: 2.698
Authors: Jennifer N Stinson; Lindsay A Jibb; Cynthia Nguyen; Paul C Nathan; Anne Marie Maloney; L Lee Dupuis; J Ted Gerstle; Benjamin Alman; Sevan Hopyan; Caron Strahlendorf; Carol Portwine; Donna L Johnston; Mike Orr Journal: J Med Internet Res Date: 2013-03-08 Impact factor: 5.428
Authors: Saad Abdulrahman Hussain; Hazha Abdulah Mohammed Ameen; Mohammed Omer Mohammed; Khadija Muhamed Ahmed; Rebaz Hama-Gareb Ali; Banaz Mubarak Safar; Kamal Ahmed Saeed Journal: Biomed Res Int Date: 2019-10-30 Impact factor: 3.411